NCT00266409View on ClinicalTrials.gov

Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

418

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Generalized Anxiety DisorderPanic Disorder
Interventions
DRUG

Niravam

DRUG

SSRI/SNRI

Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor

Trial Locations (1)

Unknown

Schwarz, Milwaukee

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY

NCT00266409 - Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder | Biotech Hunter | Biotech Hunter